A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
Melissa Lumish, M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen, Claire F. Friedman, Rachel N. Grisham, Jason Konner, Chrisann Kyi, Maria M. Rubinstein, Tiffany A. Troso-Sandoval, Carol Aghajanian, Vicky Makker
Topics & Concepts
MedicineCarcinosarcomaTrastuzumabEndometrial cancerClinical endpointOncologyCarcinomaInternal medicineCancerPhases of clinical researchChemotherapyClinical trialBreast cancerHER2/EGFR in Cancer ResearchEndometrial and Cervical Cancer TreatmentsAdvanced Biosensing Techniques and Applications